Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity: Prespecified Subgroup Analysis of the ANNEXA-4 Study in Japan.

Toyoda, Kazunori; Arakawa, Shuji; Ezura, Masayuki; Kobayashi, Rei; Tanaka, Yoshihide; Hasegawa, Shu; Yamashiro, Shigeo; Komatsu, Yoji; Terasawa, Yuka; Masuno, Tomohiko; Kobayashi, Hiroshi; Oikawa, Suzuko; Yasaka, Masahiro

Toyoda, Kazunori; Arakawa, Shuji; Ezura, Masayuki; Kobayashi, Rei; Tanaka, Yoshihide; Hasegawa, Shu; Yamashiro, Shigeo; Komatsu, Yoji; Terasawa, Yuka; Masuno, Tomohiko; Kobayashi, Hiroshi; Oikawa, Suzuko; Yasaka, Masahiro.

Afiliación

Toyoda K; Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center.
Arakawa S; Department of Neurology, Steel Memorial Yawata Hospital.
Ezura M; National Hospital Organization Sendai Medical Center.
Kobayashi R; Department of Neurology, National Hospital Organization Nagoya Medical Center.
Tanaka Y; Yokosuka Kyosai Hospital.
Hasegawa S; Department of Neurosurgery, Japanese Red Cross Kumamoto Hospital.
Yamashiro S; Division of Neurosurgery, Department of Cerebrovascular Medicine and Surgery, Saiseikai Kumamoto Hospital.
Komatsu Y; Department of Neurosurgery, Hitachi General Hospital.
Terasawa Y; Brain Attack Center Ota Memorial Hospital.
Masuno T; Nippon Medical School Hospital.
Kobayashi H; Research and Development, Alexion, AstraZeneca Rare Disease.
Oikawa S; Research and Development, Bristol Myers Squibb.
Yasaka M; Department of Cerebrovascular Medicine and Neurology, National Hospital Organization Kyushu Medical Center.

J Atheroscler Thromb ; 31(3): 201-213, 2024 Mar 01.

Article en En | MEDLINE | ID: mdl-37635060

Asunto(s)

Hemostáticos; Piridinas; Tiazoles; Trombosis; Humanos; Inhibidores del Factor Xa/efectos adversos; Rivaroxabán/efectos adversos; Factor Xa/uso terapéutico; Factor Xa/farmacología; Japón; Estudios Prospectivos; Hemorragia/tratamiento farmacológico; Hemorragia/prevención & control; Hemorragia/inducido químicamente; Antitrombina III/uso terapéutico; Hemostáticos/uso terapéutico; Trombosis/tratamiento farmacológico; Fibrinolíticos; Proteínas Recombinantes/efectos adversos; Anticoagulantes/efectos adversos

Palabras clave

Anticoagulation; Antidote; Asian; Bleeding; Intracranial hemorrhage

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Piridinas / Tiazoles / Trombosis / Hemostáticos Límite: Humans País/Región como asunto: Asia Idioma: En Revista: J Atheroscler Thromb Asunto de la revista: ANGIOLOGIA Año: 2024 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google